And the scorpion and the massasauga are both venomous ... for all of the different diseases that rodents and their ticks can transmit to us as humans. And so both of these species have tremendous ...

They’re venomous cannibals, hiding in our homes. With something like fifteen quadrillion spiders around, we can’t escape them ...

Now, at 34,793 miles, the owner suddenly started hearing "an incredibly loud tick" coming from under the ... It is the 6.7-liter Scorpion diesel engine, which pumps out 475 horsepower and 1,050 ...

"We have a huge wealth of knowledge about snake venoms and scorpion venoms and spider venoms ... this summer could be the worst yet for tick-borne infections like Lyme disease.

It would appear size isn’t everything, and perhaps, there is a replacement for displacement. Ducati downsizing its ...

And it ticks a lot of practicality boxes ... Ground clearance is listed as 225mm and wading depth is 600mm. The tyres – Pirelli Scorpion ATR all-terrain light truck tyres (275/60R20) – aren’t that ...

I’m about as into cars as your average Green Party member, but even I’ve heard all about Goodyear tyres. The brand is huge in things four-wheeled and engined, but yet to make a bigger impact in ...

Ah, the scorpion lollipop, a symbol of the Sonoran Desert. I like them, if only for the campiness of the dark, goth-looking scorpion encased unhappily in a gentle green, pink or blue. That said, ...

We look forward to leveraging the great work of the Scorpion team to date, along with Lilly's deep expertise in breast cancer, to further advance STX-478 with speed and focus." Under the terms of ...

Eli Lilly is reenergizing its attempt to challenge Novartis and Roche for a breast cancer market, kicking off the J.P. Morgan Healthcare Conference with a deal to buy Scorpion Therapeutics ...

Jan 13 (Reuters) - Eli Lilly (LLY.N), opens new tab said on Monday it plans to buy Scorpion Therapeutics' experimental cancer therapy for up to $2.5 billion in cash to expand its pipeline of ...

SAN FRANCISCO — Eli Lilly said Monday it would acquire a cancer program from startup Scorpion Therapeutics in a deal worth up to $2.5 billion, as the Indianapolis company broadens its pipeline.